Showing results (41-50 of 214) with videos related to
Sort By:
Pageof 22
JCI Insight|October 6, 2017
Antiinflammatory effects of aprepitant coadministration with cART regimen containing ritonavir in HIV-infected adultsSergei Spitsin, Pablo Tebas, Jeffrey S Barrett, et al.Plos One|September 21, 2011
A randomized, placebo controlled, double masked phase IB study evaluating the safety and antiviral activity of aprepitant, a neurokinin-1 receptor antagonist in HIV-1 infected adultsPablo Tebas, Florin Tuluc, Jeffrey S Barrett, et al.Clinical Chemistry|April 8, 2006
Real-time nucleic acid sequence-based amplification assay to quantify changes in mitochondrial DNA concentrations in cell cultures and blood cells from HIV-infected patients receiving antiviral therapyEveline C Timmermans, Pablo Tebas, Jos P N Ruiter, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 26, 2007
Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384Michael P Dubé, Lauren Komarow, Kathleen Mulligan, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trialKathleen Mulligan, Robert A Parker, Lauren Komarow, et al.European Journal of Immunology|June 4, 2021
Identification of the predominant human NK cell effector subset mediating ADCC against HIV-infected targets coated with BNAbs or plasma from PLWHCostin Tomescu, Kyle Kroll, Krystal Colon, et al.Kidney International|March 26, 2015
Superior outcomes in HIV-positive kidney transplant patients compared with HCV-infected or HIV/HCV-coinfected recipientsDeirdre Sawinski, Kimberly A Forde, Kevin Eddinger, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 20, 2007
Enfuvirtide does not require dose adjustment in patients with chronic kidney failure: results of a pharmacokinetic study of enfuvirtide in HIV-1-infected patients with impaired kidney functionPablo Tebas, Nicholas Bellos, Christopher Lucasti, et al.AIDS (London, England)|February 2, 2023
A prospective 18 F-fluorodeoxyglucose positron emission tomography/computed tomography study of the neurometabolic effects in cocaine use and HIV infectionRamya S Mamidi, Cyrus Ayubcha, Grant Rigney, et al.Infectious Diseases and Therapy|March 2, 2018
Tenofovir-Associated Bone Adverse Outcomes among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant AntiretroviralsJoanne LaFleur, Adam P Bress, Joel Myers, et al.Pageof 22